Causal relationship between immune cells and neurodegenerative diseases: a two-sample Mendelian randomisation study.

Chao Tang, Xiaoyang Lei, Yaqi Ding, Sushuang Yang, Yayu Ma, Dian He
Author Information
  1. Chao Tang: Department of Neurology, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
  2. Xiaoyang Lei: Department of Neurology, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
  3. Yaqi Ding: Department of Neurology, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
  4. Sushuang Yang: Department of Neurology, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
  5. Yayu Ma: Department of Neurology, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
  6. Dian He: Department of Neurology, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.

Abstract

Background: There is increasing evidence that the types of immune cells are associated with various neurodegenerative diseases. However, it is currently unclear whether these associations reflect causal relationships.
Objective: To elucidate the causal relationship between immune cells and neurodegenerative diseases, we conducted a two-sample Mendelian randomization (MR) analysis.
Materials and methods: The exposure and outcome GWAS data used in this study were obtained from an open-access database (https://gwas.mrcieu.ac.uk/), the study employed two-sample MR analysis to assess the causal relationship between 731 immune cell features and four neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS). All immune cell data was obtained from Multiple MR methods were used to minimize bias and obtain reliable estimates of the causal relationship between the variables of interest and the outcomes. Instrumental variable selection criteria were restricted to ensure the accuracy and effectiveness of the causal relationship between species of immune cells and the risk of these neurodegenerative diseases.
Results: The study identified potential causal relationships between various immune cells and different neurodegenerative diseases. Specifically, we found that 8 different types of immune cells have potential causal relationships with AD, 1 type of immune cells has potential causal relationships with PD, 6 different types of immune cells have potential causal relationships with ALS, and 6 different types of immune cells have potential causal relationships with MS.
Conclusion: Our study, through genetic means, demonstrates close causal associations between the specific types of immune cells and AD, PD, ALS and MS, providing useful guidance for future clinical researches.

Keywords

References

  1. Mol Neurodegener. 2020 Jun 5;15(1):32 [PMID: 32503641]
  2. Front Neurol. 2018 Oct 16;9:870 [PMID: 30386290]
  3. Int J Epidemiol. 2017 Dec 1;46(6):1985-1998 [PMID: 29040600]
  4. BMC Neurol. 2021 Apr 12;21(1):157 [PMID: 33845794]
  5. J Leukoc Biol. 2007 Nov;82(5):1083-94 [PMID: 17675560]
  6. Biol Psychiatry. 1998 Oct 15;44(8):775-7 [PMID: 9798082]
  7. Adv Exp Med Biol. 2013;785:95-105 [PMID: 23456842]
  8. Mol Neurodegener. 2022 Aug 24;17(1):55 [PMID: 36002854]
  9. Neurobiol Stress. 2018 May 19;9:9-21 [PMID: 29992181]
  10. Cell. 2002 Jun 28;109(7):901-12 [PMID: 12110186]
  11. J Neuroimmunol. 2019 Jan 15;326:49-54 [PMID: 30476705]
  12. Neuron. 2013 May 22;78(4):631-43 [PMID: 23623698]
  13. J Neuroimmunol. 1991 Dec;35(1-3):211-7 [PMID: 1659587]
  14. Nat Genet. 2013 Dec;45(12):1452-8 [PMID: 24162737]
  15. Curr Opin Neurol. 2021 Apr 1;34(2):228-236 [PMID: 33560670]
  16. Proc Natl Acad Sci U S A. 2004 Jun 22;101(25):9435-40 [PMID: 15197276]
  17. Eur J Epidemiol. 2017 May;32(5):377-389 [PMID: 28527048]
  18. Cell. 2010 Mar 19;140(6):918-34 [PMID: 20303880]
  19. Nat Genet. 2013 Nov;45(11):1353-60 [PMID: 24076602]
  20. Hum Mol Genet. 2020 Oct 10;29(17):2920-2935 [PMID: 32803224]
  21. BMC Psychiatry. 2023 Aug 15;23(1):590 [PMID: 37582716]
  22. Neurodegener Dis. 2020;20(2-3):110-112 [PMID: 32980850]
  23. Cells. 2022 Oct 31;11(21): [PMID: 36359827]
  24. J Neuroimmunol. 2017 Aug 15;309:12-22 [PMID: 28601280]
  25. Lancet Neurol. 2019 Dec;18(12):1091-1102 [PMID: 31701892]
  26. Eur J Epidemiol. 2015 Jul;30(7):543-52 [PMID: 25773750]
  27. Mol Aspects Med. 2023 Apr;90:101111 [PMID: 35940942]
  28. Cell Immunol. 1995 Aug;164(1):20-7 [PMID: 7634349]
  29. Int J Mol Sci. 2022 Oct 25;23(21): [PMID: 36361643]
  30. Neurochem Int. 2021 Nov;150:105186 [PMID: 34530055]
  31. Biol Psychiatry. 2023 May 1;93(9):770-779 [PMID: 36759259]
  32. Nat Genet. 2020 Oct;52(10):1036-1045 [PMID: 32929287]
  33. Mov Disord. 2019 Nov;34(11):1711-1721 [PMID: 31449711]
  34. Transl Psychiatry. 2022 Oct 3;12(1):427 [PMID: 36192375]
  35. EMBO Mol Med. 2019 Jun;11(6): [PMID: 31015277]
  36. Int J Epidemiol. 2015 Apr;44(2):512-25 [PMID: 26050253]
  37. Stat Med. 2011 May 20;30(11):1312-23 [PMID: 21432888]
  38. Gerontology. 2019;65(4):323-331 [PMID: 30541012]
  39. Int J Mol Sci. 2020 Sep 23;21(19): [PMID: 32977677]
  40. Methods Mol Biol. 2017;1666:581-628 [PMID: 28980266]
  41. Int J Biometeorol. 2016 Nov;60(11):1775-1785 [PMID: 27061289]
  42. J Neuroimmunol. 2023 Aug 15;381:578128 [PMID: 37321014]
  43. Immunity. 2022 Dec 13;55(12):2236-2254 [PMID: 36351425]
  44. Immunity. 2019 Apr 16;50(4):955-974 [PMID: 30995509]
  45. Neurobiol Dis. 2019 Dec;132:104589 [PMID: 31454549]
  46. J Alzheimers Dis. 2022;87(1):211-222 [PMID: 35275534]
  47. Acta Neuropathol. 2014 Nov;128(5):651-63 [PMID: 25284487]
  48. Alzheimers Res Ther. 2015 Aug 19;7(1):56 [PMID: 26286145]
  49. Crit Rev Immunol. 2011;31(1):73-84 [PMID: 21395513]
  50. J Neuroimmune Pharmacol. 2015 Dec;10(4):587-94 [PMID: 26148561]
  51. Front Immunol. 2023 Jul 28;14:1233870 [PMID: 37575227]
  52. Mov Disord. 2023 Jul;38(7):1143-1155 [PMID: 37157885]
  53. J Neuroinflammation. 2014 Dec 02;11:201 [PMID: 25441979]
  54. J Parkinsons Dis. 2022;12(s1):S149-S163 [PMID: 35723115]
  55. Neuron. 2019 Sep 4;103(5):820-835.e7 [PMID: 31301936]
  56. Nat Genet. 2021 Dec;53(12):1636-1648 [PMID: 34873335]
  57. Nat Med. 2011 Sep 18;17(10):1290-7 [PMID: 21926977]
  58. Neurobiol Aging. 2020 Aug;92:82-91 [PMID: 32408056]
  59. Res Synth Methods. 2019 Dec;10(4):486-496 [PMID: 30861319]
  60. Cold Spring Harb Perspect Med. 2022 May 17;12(4): [PMID: 34872952]
  61. IARC Sci Publ. 2011;(163):407-19 [PMID: 22997874]
  62. Annu Rev Pathol. 2022 Jan 24;17:121-139 [PMID: 34606377]
  63. J Am Soc Nephrol. 2016 Nov;27(11):3253-3265 [PMID: 27486138]
  64. Curr Opin Immunol. 1997 Jun;9(3):380-9 [PMID: 9203416]
  65. J Alzheimers Dis. 2015;47(1):177-84 [PMID: 26402766]
  66. Immunology. 2018 Jun;154(2):204-219 [PMID: 29513402]
  67. Acta Neuropathol. 2021 Apr;141(4):527-545 [PMID: 33555429]
  68. Biochemistry (Mosc). 2018 Sep;83(9):1104-1116 [PMID: 30472949]
  69. Int J Mol Sci. 2022 Mar 26;23(7): [PMID: 35408990]
  70. Nat Rev Neurosci. 2019 Dec;20(12):728-745 [PMID: 31712781]
  71. Nat Commun. 2023 Nov 20;14(1):7529 [PMID: 37981650]
  72. Curr Epidemiol Rep. 2017;4(4):330-345 [PMID: 29226067]
  73. Stat Med. 2015 Sep 20;34(21):2926-40 [PMID: 25950993]
  74. J Biol Chem. 2022 Jun;298(6):101960 [PMID: 35452678]

MeSH Term

Humans
Neurodegenerative Diseases
Amyotrophic Lateral Sclerosis
Alzheimer Disease
Parkinson Disease
Causality
Multiple Sclerosis

Word Cloud

Created with Highcharts 10.0.0immunecellscausalneurodegenerativediseasesrelationshipstypesrelationshipstudypotentialdiseasesclerosisdifferenttwo-sampleMendelianMRADPDALSMSvariousassociationsrandomizationanalysisdatausedobtainedcellamyotrophiclateralmultiple6Background:increasingevidenceassociatedHowevercurrentlyunclearwhetherreflectObjective:elucidateconductedMaterialsmethods:exposureoutcomeGWASopen-accessdatabasehttps://gwasmrcieuacuk/employedassess731featuresfourincludingAlzheimer'sParkinson'sMultiplemethodsminimizebiasobtainreliableestimatesvariablesinterestoutcomesInstrumentalvariableselectioncriteriarestrictedensureaccuracyeffectivenessspeciesriskResults:identifiedSpecificallyfound81typeConclusion:geneticmeansdemonstratesclosespecificprovidingusefulguidancefutureclinicalresearchesCausaldiseases:randomisationAlzheimer’sParkinson’s

Similar Articles

Cited By